Glioblastoma with Oligodendroglioma Component (GBM‐O): Molecular Genetic and Clinical Characteristics

Glioblastoma (GBM) is an aggressive primary brain tumor with an average survival of approximately 1 year. A recently recognized subtype, glioblastoma with oligodendroglioma component (GBM‐O), was designated by the World Health Organization (WHO) in 2007. We investigated GBM‐Os for their clinical and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Brain Pathol
Autors principals: Appin, Christina L., Gao, Jingjing, Chisolm, Candace, Torian, Mike, Alexis, Dianne, Vincentelli, Cristina, Schniederjan, Matthew J., Hadjipanayis, Costas, Olson, Jeffrey J., Hunter, Stephen, Hao, Chunhai, Brat, Daniel J.
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2013
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4868066/
https://ncbi.nlm.nih.gov/pubmed/23289977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bpa.12018
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars